508 A National Comprehensive Cancer Network phase II study of gemcitabine and irinotecan in metastatic breast cancer: can topoisomerase I localization predict response to irinotecan?

✍ Scribed by S. Moulder; N. Valkov; S. Minton; P. Munster; R. Lush; M. Lacevic; I. Sims; A. Cammarata; J. Horton; D. Sullivan

• Book ID: 118621690
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 135 KB
• Volume: 2
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(04)80516-0